2026 Update: Ro's Medication Availability and Pricing Structure Have Changed
Following the FDA's 2025 removal of tirzepatide and semaglutide from the drug shortage list, Ro has stopped accepting new compounded tirzepatide prescriptions, transitioning existing tirzepatide patients toward brand-name alternatives (Zepbound, via insurance). Ro's compounded semaglutide availability has also been reported as being phased out for new patients by some independent reviews — verify current availability directly. Separately, Ro's actual pricing model involves a distinct Ro Body membership fee (reported around $149/month, sometimes with a discounted first month) billed separately from medication cost — not a single all-inclusive dose-tier price as sometimes advertised. This review reflects these changes.
Ro vs Found: Two Different Philosophies
Comparing Ro and Found isn't just a pricing comparison — it's a comparison of two different philosophies about what GLP-1 telehealth should be. Ro's approach is pharmacy-integrated and streamlined: fast onboarding, direct medication delivery from an owned pharmacy infrastructure, and a clean clinical model without behavioral overlays — though its medication menu is actively shifting toward brand-name products. Found's approach is coaching-intensive: medication (including compounded tirzepatide, which Ro no longer offers to new patients) bundled with behavioral support, community features, and a more comprehensive weight management framework.
Both are legitimate platforms. The question is which philosophy — and which current medication menu — matches what you actually need, and how both compare to Luma Health's flat-rate compounded alternative.
Quick Snapshot: Three Platforms
Ro Body: The Integrated Pharmacy Model, Now Transitioning
Ro Body — What Makes It Different
Ro's most significant structural differentiator is their integrated pharmacy model. Ro owns their pharmacy operations rather than outsourcing to a third-party compounder. This gives them more direct quality control over medication preparation and a streamlined supply chain — though it now applies primarily to a narrowing menu of compounded products and a growing brand-name lineup.
Ro's actual billing model separates a Ro Body membership fee (reported around $149/month) from medication cost, so the effective all-in monthly total is higher than a single advertised medication price suggests. Ro has stopped accepting new compounded tirzepatide prescriptions, directing new tirzepatide-seeking patients toward brand-name Zepbound via insurance coordination instead. Ro also offers video consultations and one of the stronger insurance coordination pathways for brand-name Wegovy and Zepbound among GLP-1 telehealth platforms.
- ✓ Integrated pharmacy — Ro owns dispensing operations
- ✓ Video consultations available
- ✓ Insurance nav for brand Wegovy/Zepbound
- ✓ Optional metabolic lab work
- ⚠ No longer accepts new compounded tirzepatide patients
- ⚠ Separate ~$149/mo membership fee + medication cost
- ✗ No behavioral coaching
Found — What Makes It Different
Found was purpose-built as a weight management platform from the start, integrating behavioral health coaching into the core offering rather than treating it as an optional add-on. Their coaches work alongside the medication prescribing throughout the treatment course, and their app includes community features, habit tracking, and structured behavioral content.
Found also offers medication flexibility beyond GLP-1: for patients who don't tolerate or qualify for semaglutide or tirzepatide, Found can prescribe other weight management medications. Found continues to offer compounded tirzepatide at approximately $199 to $249/month — a meaningful advantage now that Ro has stopped accepting new compounded tirzepatide patients.
- ✓ Behavioral coaching included
- ✓ Community / peer support features
- ✓ Compounded tirzepatide still available (~$199–$249/mo)
- ✓ Non-GLP-1 medication options available
- ✗ Dose-tier price increases at maintenance
- ✗ Pharmacy not prominently disclosed
Pricing Deep Dive: What You Actually Pay
The most important pricing insight for Ro is that its advertised medication price is not the full cost — a separate membership fee applies on top. For Found, the key insight is the difference between advertised starting price and maintenance-dose reality, since patients spend most of their treatment time at maintenance doses.
| Pricing Scenario | Ro Body | Found | Luma Health |
|---|---|---|---|
| Membership/program fee | ~$149/mo (separate from medication) | Included in medication price | $0 |
| Compounded sema (if available) | Verify current availability | ~$129–$199/mo (dose-tier) | $197/mo flat |
| Compounded tirz | No longer offered to new patients | ~$199–$249/mo | $297/mo flat |
| Brand Zepbound (tirz, via insurance) | Insurance-dependent | Limited | Not offered (compounded only) |
| Effective total (sema, self-pay) | ~$294–$378/mo (membership + med.) | ~$129–$199/mo | $197/mo flat, all-in |
Full Three-Way Feature Comparison
| Factor | Ro Body | Found | Luma Health |
|---|---|---|---|
| Compounded tirzepatide | No longer accepting new patients | ✓ Available (~$199–$249/mo) | $297/mo flat |
| Compounded semaglutide | Verify current availability | ~$129–$199/mo (dose-tier) | $197/mo flat |
| Behavioral coaching | No | ✓ Included | Not included |
| Video consultations | ✓ Available | Messaging primarily | Not offered |
| Pharmacy model | ✓ Integrated (own facilities) | Partner 503A | VialsRX TX #35264 (named) |
| Insurance nav (brand) | ✓ Wegovy/Zepbound | Limited | Cash-pay only |
| Membership fee structure | Separate ~$149/mo fee | Included in price | None |
| Non-GLP-1 medications | Limited | ✓ Available (naltrexone-bupropion, etc.) | GLP-1 focus |
| Pharmacy publicly named | Ro-owned (named) | Not prominently | ✓ VialsRX, TX #35264, verifiable |
| Platform longevity | ✓ 8+ years, well-funded | Founded 2020 | Newer platform |
Who Each Platform Is Right For
Choose Ro If...
- You have commercial insurance and want the strongest insurance navigation pathway for brand-name Wegovy or Zepbound
- You want video consultations with providers and optional metabolic lab work for a more clinically engaged experience
- Platform stability matters — 8-year track record and substantial institutional backing
- You do not need compounded tirzepatide specifically, since Ro is no longer accepting new patients for that medication
Choose Found If...
- You specifically want compounded tirzepatide — Found still offers it, unlike Ro for new patients
- Behavioral coaching alongside your GLP-1 is important and you will consistently engage with Found's health coaches and habit-tracking tools
- You need medication flexibility — Found's non-GLP-1 pathways matter if you can't tolerate or qualify for semaglutide or tirzepatide
- Found's lower starting sema price (~$129/mo) fits your budget in the early treatment months, with no separate membership fee
★ Choose Luma Health If...
- You want flat-rate pricing at every dose — $197/mo sema and $297/mo tirz, no surprises at maintenance, no separate membership fee
- You're a cash-pay patient without realistic insurance coverage and want the most predictable annual cost for a 12+ month treatment course
- Pharmacy transparency before you pay — VialsRX (TX #35264) publicly named and verifiable at pharmacy.texas.gov
- You want reliable, ongoing access to compounded tirzepatide as a core offering rather than a discontinued option
Compounded tirzepatide, still available.
$297/mo flat, no membership fee.
Compounded semaglutide $197/month flat, tirzepatide $297/month flat. VialsRX pharmacy (TX Board #35264). No contracts.
Start With Luma Health →Frequently Asked Questions
Found is generally more straightforward and often cheaper for cash-pay patients. Ro's pricing model separates a membership fee (~$149/month) from medication cost, so the effective total for compounded semaglutide can reach $294–$378/month depending on dose. Found's semaglutide pricing (~$129–$199/month, dose-tier) already includes coaching and clinical services in one price. For tirzepatide specifically, Found is the more relevant comparison since Ro no longer accepts new compounded tirzepatide patients. Luma Health at $197/month flat (sema) and $297/month flat (tirz) has no separate membership fee and no dose-tier increases.
No, not for new patients. Following the FDA's 2025 removal of tirzepatide from the drug shortage list and subsequent enforcement, Ro stopped accepting new compounded tirzepatide prescriptions, directing new tirzepatide-seeking patients toward brand-name Zepbound via insurance coordination instead. Existing Ro tirzepatide patients were offered transition guidance. If you specifically want compounded tirzepatide, Found and Luma Health remain viable options.
Yes. Found includes behavioral health coaching — health coaches, in-app messaging, habit tracking tools, and community features — as part of its bundled subscription. Ro provides licensed provider consultations (including video consults) and clinical oversight but does not include dedicated behavioral coaches. Whether Found's coaching justifies its cost depends on how consistently you will use it.
Ro owns and operates its own pharmacy facilities rather than outsourcing compounding to third-party partners. This integrated model gives Ro more direct quality control over medication preparation and supports Ro's insurance coordination work for brand-name Wegovy and Zepbound. For cash-pay compounded medication quality, the distinction between Ro's own pharmacy and a properly licensed 503A partner pharmacy (like VialsRX, TX #35264, used by Luma Health) is less significant than the total price difference between platforms, especially given Ro's separate membership fee.
Ro has meaningfully stronger insurance navigation infrastructure for brand-name Wegovy and Zepbound than Found. For patients with commercial insurance who want to pursue prior authorization for brand-name medication — which can reduce cost to as little as $25/month with the manufacturer savings card — Ro's experience and pharmacy integration provide a genuine advantage. Found's insurance navigation capabilities are more limited.
Complete Luma Health's online intake at start.mylumahealth.com while you still have 2 to 3 weeks of your current medication remaining. Inform your Wasef Health, PC provider of your current medication type and dose — no titration restart is required when switching providers on the same GLP-1 molecule. Wait for VialsRX shipping confirmation (5–10 business days) before canceling your Ro or Found subscription. Check your current plan for any contract or membership cancellation terms before canceling.
References
- Wilding JPH, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1). N Engl J Med. 2021;384(11):989–1002. PubMed 33567185
- Jastreboff AM, et al. Tirzepatide Once Weekly for the Treatment of Obesity (SURMOUNT-1). N Engl J Med. 2022;387(3):205–216. PubMed 35658024
- Wadden TA, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy. JAMA. 2021;325(14):1403–1413. PubMed 33755729
- U.S. Food and Drug Administration. Human Drug Compounding — Section 503A. FDA.gov
- NABP. Compounding Pharmacy Accreditation. nabp.pharmacy
- Ro Body. Weight Loss Program. ro.co
- Found Health. Weight Loss Program. joinfound.com
- NIDDK. Prescription Medications to Treat Overweight & Obesity. niddk.nih.gov